Michèle Beau‐Faller

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Fabrice Barlési, Julien Mazières, Jean‐Philippe Merlio et al. · The Lancet · 2016 · 984 citations

Medicine, Molecular Medicine, Oncology +11

Lung Cancer That Harbors an <i>HER2</i> Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

Julien Mazières, Solange Peters, Benoît Lepage et al. · Journal of Clinical Oncology · 2013 · 659 citations

Medicine, Molecular Genetics, Oncology +15

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort

Julien Mazières, Fabrice Barlési, Thomas Filleron et al. · Annals of Oncology · 2015 · 330 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Michèle Beau‐Faller, Nathalie Prim, Anne-Marie Ruppert et al. · Annals of Oncology · 2013 · 320 citations · Full text

Medicine, Genetics, Oncology +7

MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort

Michèle Beau‐Faller, Anne-Marie Ruppert, Anne‐Claire Voegeli et al. · Journal of Thoracic Oncology · 2008 · 199 citations · Full text

Medicine, Molecular Genetics, Oncology +16